Literature DB >> 11237826

Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission.

J K Pullium1, D R Adams, E Jackson, C N Kim, D K Smith, R Janssen, K Gould, T M Folks, S Butera, R A Otten.   

Abstract

Characterizing human immunodeficiency virus (HIV) expression in semen during primary infection remains essential to understanding the risk of sexual transmission. This investigation represents the first systematic evaluation of male genital tract shedding to use a nonhuman primate model, including the impact of exposure route and viral virulence. Male macaques were inoculated with either a chronic disease-causing virus (HIV-2(GB122); n=4 intravenous; n=4 intrarectal) or an acutely pathogenic simian/HIV strain (SHIV(89.6P); n=2 intravenous). All macaques were systemically infected, and seminal plasma virion-associated RNA (vRNA) levels were approximately 10-fold lower than those in blood. In HIV-2(GB122) infection, seminal virus was delayed by 1-2 weeks compared with that in blood. Intrarectal inoculation resulted in a shorter duration of seminal vRNA expression and intermittent seminal cell provirus. No delays, higher peaks ( approximately 50-fold), or longer durations in seminal virus expression were noted for SHIV(89.6P) infection. This novel model definitively establishes that virus dissemination results in early peak seminal levels and provides a basis for evaluating interventions targeting male genital tract expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237826     DOI: 10.1086/319293

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

Review 1.  Approaching "HIV elimination": interventions for acute HIV infection.

Authors:  Christopher D Pilcher; Lisa Eaton; Seth Kalichman; Cláudia Bisol; Ricardo da Silva de Souza
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

2.  Nonpathogenic CCR2-tropic SIVrcm after serial passage and its effect on SIVmac infection of Indian rhesus macaques.

Authors:  Binhua Ling; Ronald S Veazey; Preston A Marx
Journal:  Virology       Date:  2008-07-26       Impact factor: 3.616

3.  HIV-1 Populations in Semen Arise through Multiple Mechanisms.

Authors:  Jeffrey A Anderson; Li-Hua Ping; Oliver Dibben; Cassandra B Jabara; Leslie Arney; Laura Kincer; Yuyang Tang; Marcia Hobbs; Irving Hoffman; Peter Kazembe; Corbin D Jones; Persephone Borrow; Susan Fiscus; Myron S Cohen; Ronald Swanstrom
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

Review 4.  Acute HIV revisited: new opportunities for treatment and prevention.

Authors:  Christopher D Pilcher; Joseph J Eron; Shannon Galvin; Cynthia Gay; Myron S Cohen
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

5.  Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection.

Authors:  Christopher D Pilcher; George Joaki; Irving F Hoffman; Francis E A Martinson; Clement Mapanje; Paul W Stewart; Kimberly A Powers; Shannon Galvin; David Chilongozi; Syze Gama; Matthew A Price; Susan A Fiscus; Myron S Cohen
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

6.  Impact of early cART on HIV blood and semen compartments at the time of primary infection.

Authors:  Antoine Chéret; Christine Durier; Adeline Mélard; Mickaël Ploquin; Julia Heitzmann; Camille Lécuroux; Véronique Avettand-Fenoël; Ludivine David; Gilles Pialoux; Jean-Marie Chennebault; Michaela Müller-Trutwin; Cécile Goujard; Christine Rouzioux; Laurence Meyer
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

7.  Infection of semen-producing organs by SIV during the acute and chronic stages of the disease.

Authors:  Anna Le Tortorec; Roger Le Grand; Hélène Denis; Anne-Pascale Satie; Karim Mannioui; Pierre Roques; Anne Maillard; Sylvanne Daniels; Bernard Jégou; Nathalie Dejucq-Rainsford
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.